Araclon Biotech产品介绍

www.araclon.com

Araclon Biotech位于西班牙，成立于2004年，致力于为退行性疾病的诊断和治疗研究提供产品和解决方案，尤其是阿尔茨海默氏症。目前，Araclon分别从三方面开展工作，首先由专业的小组关注阿尔茨海默氏症的诊断试剂的开发，其次，是免疫治疗方面的产品，zui后为没有症状表现的个体提供阿尔茨海默氏症的预测。

Araclon Biotech is a newly founded company dedicated to the research and development of therapies and diagnostic methods to be applied to degenerative diseases, in particular, to date, to Alzheimer’s disease. Currently, Araclon is working on three different projects,

The first one focuses on the diagnosis of Alzheimer’s disease （with a patented detection kit for Beta-amyloid 40 and 42 proteins in blood）.

The second one on immunotherapy.

And the last one is an emerging project which tries to answer the challenge of predicting Alzheimer’s disease in totally asymptomatic individuals.